drugset / Trial / NCT00657761
Metabolic Effects of Enfuvirtide in Healthy Volunteers
RandomizedCrossoverQuadruple-blind
Summary
The metabolic effects of T-20 are not completely known, since the drug is used in combination with other antiretroviral agents. A short-term study in healthy volunteers, with a double-blind crossover design vs. placebo will illustrate if there may be some direct metabolic effects without the influence of HIV infection and the concurrent use of other drugs.
Timeline
- Start
- 2005-09
- Primary completion
- 2006-03
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enfuvirtide | Peptide | 90 mg | Subcutaneous |